RELX (REN.AS) Stock Analysis & Winston Score
RELX is a British company that sells information, data, and tools to professionals like doctors, lawyers, scientists, and risk analysts. Its main brands include Elsevier, which publishes scientific and medical research journals, LexisNexis, which provides legal research tools, and Reed Exhibitions, which runs large trade shows and conferences around the world. It is one of the largest academic and professional information providers globally. RELX makes most of its money through subscriptions and licenses, meaning customers pay recurring fees to access its databases and research platforms. It operates primarily in North America and Europe, generating roughly $9–10 billion in annual revenue, and its deep archives of scientific and legal content are difficult for competitors to replicate. The key growth driver is its expanding use of data analytics and artificial intelligence tools built on top of its existing content, though a major risk is growing pressure from open-access publishing movements that could reduce demand for paid academic journal subscriptions.
Winston Score: 70/100 — Strong
A high-quality business with solid fundamentals.
- Quality: Exceptional (28/30)
- Growth: Strong (15/20)
- Cash Flow: Exceptional (10/10)
- Stability: Good (5/10)
- Valuation: Strong (7/10)
- Ownership: Weak (2/15)
Key Facts
Price: €30.66
Market Cap: €53.5B
Sector: Industrials
Industry: Specialty Business Services
Exchange: Euronext Amsterdam

